High Plasma Level of a Eumelanin Precursor, 6-Hydroxy-5-Methoxyindole-2-Carboxylic Acid as a Prognostic Marker for Malignant Melanoma
- 1 April 1994
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 102 (4), 501-505
- https://doi.org/10.1111/1523-1747.ep12373153
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy- 5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progressionMelanoma Research, 1991
- The Epidermal Melanin Unit in the Pathophysiology of Malignant MelanomaThe American Journal of Dermatopathology, 1991
- The Stability of 5‐S‐Cysteinyldopa and 6‐Hydroxy‐5‐Methoxyindole‐2‐Carboxylic Acid in Human UrinePigment Cell Research, 1990
- Urinary Excretion of 5-S-Cysteinyldopa in Relation to Skin Type, UVB-induced Erythema, and Melanocyte Proliferation in Human SkinJournal of Investigative Dermatology, 1988
- Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjectsJournal of the American Academy of Dermatology, 1988
- Melanin-Related Metabolites as Markers of the Skin Pigmentary SystemJournal of Investigative Dermatology, 1987
- Eumelanin-Related Indolic Compounds in the Urine of Treated Melanoma Patientscclm, 1986
- Soluble and Particulate Forms of Rat Catechol‐O‐Methyltransferase Distinguished by Gel Electrophoresis and Immune FixationJournal of Neurochemistry, 1985
- Quantitative Analysis of Eumelanin and Pheomelanin in Hair and MelanomasJournal of Investigative Dermatology, 1983
- Quantitative Determination of Dopa; Its Application to Measurement of Dopa in Urine and in the Assay of Tyrosinase in SerumJournal of Investigative Dermatology, 1964